Enhabit Inc Shs EHAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EHAB is a good fit for your portfolio.
News
-
Enhabit Home Health & Hospice Announces Date of 2024 First Quarter Earnings Call
-
Enhabit Home Health & Hospice Named a Winner of the 2024 Top Workplaces USA Award
-
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2024 Guidance
-
Enhabit Home Health & Hospice Announces Date of 2023 Fourth Quarter Earnings Call
Trading Information
- Previous Close Price
- $10.09
- Day Range
- $10.07–10.44
- 52-Week Range
- $7.12–14.59
- Bid/Ask
- $8.87 / $10.59
- Market Cap
- $510.59 Mil
- Volume/Avg
- 312,625 / 572,878
Key Statistics
- Price/Earnings (Normalized)
- 804.55
- Price/Sales
- 0.49
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Core
- Total Number of Employees
- 10,800
- Website
- https://www.ehab.com
Comparables
Valuation
|
Metric
|
EHAB
|
LFST
|
INNV
|
|---|---|---|---|
Price/Earnings (Normalized) | 804.55 | — | — |
Price/Book Value | 0.76 | 1.71 | 1.85 |
Price/Sales | 0.49 | 2.24 | 0.73 |
Price/Cash Flow | 13.84 | 140.53 | — |
Price/Earnings
EHAB
LFST
INNV
Financial Strength
|
Metric
|
EHAB
|
LFST
|
INNV
|
|---|---|---|---|
Quick Ratio | 1.42 | 1.01 | 1.16 |
Current Ratio | 1.53 | 1.11 | 1.27 |
Interest Coverage | −1.10 | −8.74 | −14.11 |
Quick Ratio
EHAB
LFST
INNV
Profitability
|
Metric
|
EHAB
|
LFST
|
INNV
|
|---|---|---|---|
Return on Assets (Normalized) | 0.76% | −4.64% | −4.91% |
Return on Equity (Normalized) | 1.60% | −6.76% | −9.13% |
Return on Invested Capital (Normalized) | 3.61% | −4.11% | −5.85% |
Return on Assets
EHAB
LFST
INNV
Medical Care Facilities Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
HCA
| HCA Healthcare Inc | Gwfwmdzlw | Vhxffy | $81.8 Bil | |
FSNUF
| Fresenius SE & Co KGaA | — | Ywrndgp | $16.9 Bil | |
FSNUY
| Fresenius SE & Co KGaA ADR | — | Zhdwzfw | $16.9 Bil | |
FMS
| Fresenius Medical Care AG ADR | Kzq | Nqqpjk | $12.5 Bil | |
FMCQF
| Fresenius Medical Care AG | — | Rwrqyk | $12.4 Bil | |
BDUUY
| Bangkok Dusit Medical Services PCL ADR | — | Tggg | $12.3 Bil | |
DVA
| DaVita Inc | Bspcgbrq | Pfqvjfv | $12.2 Bil | |
UHS
| Universal Health Services Inc Class B | — | Jtwsmn | $11.5 Bil | |
THC
| Tenet Healthcare Corp | Kzzsrwdc | Jqz | $11.3 Bil | |
AMN
| AMN Healthcare Services Inc | Mhbgyzt | Mckypd | $2.3 Bil |